SME Instrument Innovators’ Summit, Brussels

sme_innosummit_logo_primaryAs a SME champion, beneficiary of Horizon 2020 SME Instrument, COMAC Medical was invited in Brussels to the first ever SME Instrument Innovators’ Summit, organized by the European Commission Executive Agency for SMEs (EASME).

Read More..

Participation in Clinical Outsourcing World, London, UK

clinical-outsourcing-logoComac Medical Ltd. took part in Clinical Outsourcing World Event in London on 9-10 March 2016, with four delegates and own booth.

Pythagoras award for Comac Medical


On May 19th 2016, The Bulgarian Ministry of Education and Science has granted Comac Medical with Pythagoras award for “Company with biggest investment in scientific research”.

For the first time in Bulgaria it was presented an innovative method to treat speech problems in children with autism

IMG_8232Harry Schneider, PhD, MD present on the reasons why children with classical autism cannot speak. He present the results of treating these children with transcranial direct current stimulation (tDCS ).

In October 2016, Comac Medical became a member of Bulgarian Association for Drug Information


COMAC MEDICAL part of Biomedical partnership event, IFB2016, June, 16, Liverpool

Conference_titleOn June 16, Comac Medical received a grant from Enterprise Europe Network (EEN) to participate in Biomedical partnership event, incorporating all aspect of healthcare and life sciences. The event took place in Liverpool – the North West England, which is one of the UK’s top three biomedical clusters and home to the largest single site clinical campus.

Read More..

Monument of Tsar Samuil in Sofia

IMG_6349Dr. Vrabevski, chairman of Bulgarian Memory Foundation, together with the President of Bulgaria Rosen Plevneliev, the Bulgarian Patriarch Neofit and the Mayor of Sofia Yordanka Fandakova dedicated a monument to the Bulgarian tsar Samuil in the center of Sofia on 08.06.2015.

Horizon 2020 Seal of Excellence

Seal Of ExcellenceComac Medical owns a highly innovative project proposal which has been awarded with a Seal of Excellence by the European Commission.

Read More..

Horizon 2020 SME Instrument Phase 1 successfully completed

Comac Medical has successfully completed Phase 1 of Horizon 2020 SME Instrument and has submitted the project report which has been approved by the European Commission.

IMP³rove assessment

improve_logoComac Medical has conducted an assessment in IMP³rove – an instrument provided by the European Commission for measurement of the innovation potential of the company, which ranked the company among the growth champions in Europe.

Horizon 2020

horizon-2020Comac Medical has been selected to participate in Horizon 2020 Program. Please click here for more information regarding the program.

Horizon 2020 Innovation Business Breakfast 06.10.2015

Innovation-Business-Breakfast-06.10-smallComac Medical, as participant in Phase I of the Horizon 2020 SME Instrument, was invited to a business breakfast which took place on 06.10.2015 in the premises of EEN – Bulgaria. The event was organized by Cleantech Bulgaria together with Green Business Network and the Applied Research and Communications Fund.

Expansion of Clinical Operations in Albania and Kosovo

dochs We have added Albania and Kosovo to our geographical reach and we now cover 16 countries in CEE and the Baltic region.

Horizon 2020 Visit of Commissioner Carlos Moedas in Bulgaria 08.10.2015

Comac Medical, as participant in Phase I of the Horizon 2020 SME Instrument, was invited to participate in the conference which took place as part of the visit of Carlos Moedas, European commissioner for research, science and innovation, in Bulgaria. The event was organized by the Bulgarian Ministry of Science and Education together with the Research and Innovation Department of the European Commission.

Our successful development is best represented by the following

  • Coverage of 19 countries
  • 20 years experience
  • 616 completed clinical trials
  • 345 Quality of Life projects
  • 3820 study investigators
  • 820 audits/ inspections/ co-monitoring visits
  • 360 certificates of quality/ attendance/ recognition and training
  • FDA Inspected Sites, NAI Letters issued
  • FDA Pre-IND Meetings
  • EU RA Scientific Advice Meetings


  • Certificate of Recognition by USA NIH (2002)
  • FDA inspected Sites
  • EMA inspected Sites
  • FDA pre-IND Meetings
  • EU Scientific Advice Meetings on drug development programs with EU Competent Authorities
  • 24-bed (incl. 6 intensive care) Early Phase Clinical Research Center (since 2005), Certified by the Ministry of Research and Science of France
  • ISO 9001:2008 Certified and Re-certified (since 2004)
  • CDISC Partner
  • DIA Partner
  • Academia Partner
  • PSCI Principles Compliant
  • HORIZON 2020 Beneficiary

Comac Medical reach



Bulgaria (Sofia HQ) Germany Croatia Latvia Lithuania Estonia Georgia
Macedonia Romania Serbia Moldova Montenegro Slovenia Poland
Hungary Albania Kosovo Cyprus Greece Sweden Bosnia and Herzegovina
© Copyright - Comac Medical Ltd.